NovaBay reports lower net loss in 2014

NovaBay Pharmaceuticals reported a 2014 net loss of $15.2 million, or $0.31 per share, compared with $16 million, or $0.42 per share, in 2013, according to a press release.The lower net loss in 2014 was attributed to decreased spending on research and development activities. Sales revenue was $684,000 in 2014 compared with $223,000 in 2013.